553 related articles for article (PubMed ID: 29969455)
1. Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis.
Okamoto T; Hatakeyama S; Hosogoe S; Tanaka Y; Imanishi K; Takashima T; Saitoh F; Suzuki T; Ohyama C
PLoS One; 2018; 13(7):e0199160. PubMed ID: 29969455
[TBL] [Abstract][Full Text] [Related]
2. The relationship between poor nutritional status and progression of aortic calcification in patients on maintenance hemodialysis.
Okamoto T; Hatakeyama S; Kodama H; Horiguchi H; Kubota Y; Kido K; Momota M; Hosogoe S; Tanaka Y; Takashima T; Saitoh F; Suzuki T; Ohyama C
BMC Nephrol; 2018 Mar; 19(1):71. PubMed ID: 29558928
[TBL] [Abstract][Full Text] [Related]
3. Is there a relationship between hypomagnesemia and proton-pump inhibitors in patients on chronic hemodialysis?
Mikolasevic I; Milic S; Stimac D; Zaputovic L; Lukenda Zanko V; Gulin T; Jakopcic I; Klaric D; Gulin M; Orlic L
Eur J Intern Med; 2016 May; 30():99-103. PubMed ID: 26905320
[TBL] [Abstract][Full Text] [Related]
4. The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis.
Park CH; Kim EH; Roh YH; Kim HY; Lee SK
PLoS One; 2014; 9(11):e112558. PubMed ID: 25394217
[TBL] [Abstract][Full Text] [Related]
5. Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors.
Leonard CE; Bilker WB; Brensinger CM; Flockhart DA; Freeman CP; Kasner SE; Kimmel SE; Hennessy S
Stroke; 2015 Mar; 46(3):722-31. PubMed ID: 25657176
[TBL] [Abstract][Full Text] [Related]
6. Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysis.
Yamada K; Fujimoto S; Nishiura R; Komatsu H; Tatsumoto M; Sato Y; Hara S; Hisanaga S; Ochiai H; Nakao H; Eto T
Nephrol Dial Transplant; 2007 Jul; 22(7):2032-7. PubMed ID: 17395663
[TBL] [Abstract][Full Text] [Related]
7. The relationship between proton pump inhibitor use and serum magnesium concentration among hemodialysis patients: a cross-sectional study.
Misra PS; Alam A; Lipman ML; Nessim SJ
BMC Nephrol; 2015 Aug; 16():136. PubMed ID: 26268579
[TBL] [Abstract][Full Text] [Related]
8. Predictors of abdominal aortic calcification progression in patients with chronic kidney disease without hemodialysis.
Yamamoto D; Suzuki S; Ishii H; Hirayama K; Harada K; Aoki T; Shibata Y; Negishi Y; Tatami Y; Sumi T; Ichii T; Kawashima K; Kunimura A; Kawamiya T; Morimoto R; Yasuda Y; Murohara T
Atherosclerosis; 2016 Oct; 253():15-21. PubMed ID: 27573734
[TBL] [Abstract][Full Text] [Related]
9. Acute kidney injury following the use of different proton pump inhibitor regimens: A real-world analysis of post-marketing surveillance data.
Chen G; Ning LJ; Qin Y; Zhao B; Mei D; Li XM
J Gastroenterol Hepatol; 2021 Jan; 36(1):156-162. PubMed ID: 32542684
[TBL] [Abstract][Full Text] [Related]
10. Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis.
Takei T; Otsubo S; Uchida K; Matsugami K; Mimuro T; Kabaya T; Akiba T; Nitta K
Nephron Clin Pract; 2008; 108(4):c278-83. PubMed ID: 18434749
[TBL] [Abstract][Full Text] [Related]
11. Impact of Renal Functional/Morphological Dynamics on the Calcification of Coronary and Abdominal Arteries in Patients with Chronic Kidney Disease.
Ichii T; Morimoto R; Okumura T; Ishii H; Tatami Y; Yamamoto D; Aoki S; Hiraiwa H; Furusawa K; Kondo T; Watanabe N; Kano N; Fukaya K; Sawamura A; Suzuki S; Yasuda Y; Murohara T
J Atheroscler Thromb; 2017 Nov; 24(11):1092-1104. PubMed ID: 28392544
[TBL] [Abstract][Full Text] [Related]
12. Twice-daily dosing of esomeprazole effectively inhibits acid secretion in CYP2C19 rapid metabolisers compared with twice-daily omeprazole, rabeprazole or lansoprazole.
Sahara S; Sugimoto M; Uotani T; Ichikawa H; Yamade M; Iwaizumi M; Yamada T; Osawa S; Sugimoto K; Umemura K; Miyajima H; Furuta T
Aliment Pharmacol Ther; 2013 Nov; 38(9):1129-37. PubMed ID: 24099474
[TBL] [Abstract][Full Text] [Related]
13. Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study.
Falhammar H; Lindh JD; Calissendorff J; Skov J; Nathanson D; Mannheimer B
Eur J Intern Med; 2019 Jan; 59():65-69. PubMed ID: 30154038
[TBL] [Abstract][Full Text] [Related]
14. The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study.
van der Hoorn MMC; Tett SE; de Vries OJ; Dobson AJ; Peeters GMEEG
Bone; 2015 Dec; 81():675-682. PubMed ID: 26319499
[TBL] [Abstract][Full Text] [Related]
15. Serum Soluble Klotho Level Is Associated with Abdominal Aortic Calcification in Patients on Maintenance Hemodialysis.
Cai H; Lu R; Zhang M; Pang H; Zhu M; Zhang W; Ni Z; Qian J; Yan Y
Blood Purif; 2015; 40(2):120-6. PubMed ID: 26159932
[TBL] [Abstract][Full Text] [Related]
16. Association between serum magnesium levels and abdominal aorta calcification in patients with pre-dialysis chronic kidney disease stage 5.
Ito M; Yamaguchi M; Katsuno T; Nobata H; Iwagaitsu S; Sugiyama H; Kinashi H; Banno S; Ando M; Kubo Y; Ishimoto T; Ito Y
PLoS One; 2021; 16(6):e0253592. PubMed ID: 34143857
[TBL] [Abstract][Full Text] [Related]
17. The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis.
Nitta K; Akiba T; Uchida K; Kawashima A; Yumura W; Kabaya T; Nihei H
Am J Kidney Dis; 2003 Aug; 42(2):303-9. PubMed ID: 12900812
[TBL] [Abstract][Full Text] [Related]
18. Relationship between abdominal aortic and coronary artery calcification as detected by computed tomography in chronic kidney disease patients.
Takayama Y; Yasuda Y; Suzuki S; Shibata Y; Tatami Y; Shibata K; Niwa M; Sawai A; Morimoto R; Kato S; Ishii H; Maruyama S; Murohara T
Heart Vessels; 2016 Jul; 31(7):1030-7. PubMed ID: 26164596
[TBL] [Abstract][Full Text] [Related]
19. Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional Study.
Nakashima A; Ohkido I; Yokoyama K; Mafune A; Urashima M; Yokoo T
PLoS One; 2015; 10(11):e0143656. PubMed ID: 26618538
[TBL] [Abstract][Full Text] [Related]
20. Magnesium and parathyroid hormone levels of patients using different proton pump inhibitors: is there a real link?
Sarikaya M; Filik L; Ergul B; Doğan Z
Gastroenterol Nurs; 2013; 36(2):145-8. PubMed ID: 23549219
[No Abstract] [Full Text] [Related]
[Next] [New Search]
